| SYTHEON Sytheon Limited 2068575 5 Sept 2019 | Protected: Registered/protected | Chemical additives for use in the manufacture of health and beauty aid... Class 001 Class 001 Chemical Products Chemical additives for use in the manufacture of health and beauty aid products, cosmetics and skin and hair care treatment products; plant and herb extracts for use in the manufacture of health and beauty aid products, cosmetics and skin and hair care treatment products; chemical stabilizers and antioxidants for use in preservation and prevention of degradation and efficacy of cosmetics, health and beauty aid products, and skin and hair care treatment products; gene manipulating chemicals and natural extracts for use in the manufacture of cosmetics, health and beauty aid products, and skin and hair care treatment products; chemical additives and natural extracts in the nature of corrective, preventative and enhancing physiological active agents for use in the manufacture of cosmetics, health and beauty aid products, and skin and hair care treatment products. Class 003 Class 003 Cosmetics and Cleaning Products Botanical extracts for beauty aid products, cosmetics, skin and hair care treatments | |
| SYTHEIA Ocugen, Inc. 2519937 6 Feb 2025 | Accepted: Awaiting publication | Gene therapy products, namely, genetically engineered tissues for tran... Class 005 Class 005 Pharmaceutical Products Gene therapy products, namely, genetically engineered tissues for transplant purposes; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating ocular diseases; Gene therapy products, namely, rAAV vector for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant nucleic acid for treating ocular diseases; Gene therapy products, namely, recombinant nucleic acid for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant DNA for treating ocular diseases; Gene therapy products, namely, recombinant DNA for treating Retinitis Pigmentosa; Gene therapy products, namely, rAAV for treating ocular diseases such as Leber congenital amaurosis (LCA), retinitis pigmentosa, enhance S-cone syndrome, Goldmann Favre syndrome, rod-cone dystrophy Bardet-Biedl Syndrome, Achromatopsia, Best Disease (vitelliform macular degeneration), Bardet-Biedl Syndrome, Choroideremia, Macular Degeneration, Stargardt Disease, X-Linked Retinoschisis (XLRS), X-Linked Retinitis Pigmentosa (XLRP), Usher Syndrome, cone-rod dystrophy, Dry-Age related macular degeneration, and wet-Age related macular degeneration. | |
